| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 502* | 2019 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 307 | 2022 |
| Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets CW Spearman, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The lancet gastroenterology & hepatology 2 (12), 900-909, 2017 | 302 | 2017 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 247* | 2015 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 163 | 2022 |
| Hepatitis C treatment: where are we now? NJ Burstow, Z Mohamed, AI Gomaa, MW Sonderup, NA Cook, I Waked, ... International journal of general medicine, 39-52, 2017 | 155 | 2017 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2 Journal of Viral Hepatitis 22 (1), 6-25, 2015 | 142 | 2015 |
| Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030 MW Sonderup, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The Lancet Gastroenterology & Hepatology 2 (12), 910-919, 2017 | 120 | 2017 |
| Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection LG Bekker, K Rebe, F Venter, G Maartens, M Moorhouse, F Conradie, ... Southern African journal of HIV medicine 17 (1), 2016 | 110 | 2016 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2 Journal of Viral Hepatitis 22 (1), 46-73, 2015 | 91 | 2015 |
| Innovative strategies for the elimination of viral hepatitis at a national level: a country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 59 | 2019 |
| Health disparities in liver disease in sub‐Saharan Africa CW Spearman, MW Sonderup Liver International 35 (9), 2063-2071, 2015 | 54 | 2015 |
| Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey A Scheibe, K Young, L Moses, RL Basson, A Versfeld, CW Spearman, ... Harm reduction journal 16, 1-11, 2019 | 51 | 2019 |
| WGO guidance for the care of patients with COVID-19 and liver disease S Hamid, MRA Da Silva, KW Burak, T Chen, JPH Drenth, G Esmat, ... Journal of clinical gastroenterology 55 (1), 1-11, 2021 | 50 | 2021 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 47 | 2023 |
| Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study N Scott, A Palmer, C Morgan, O Lesi, CW Spearman, M Sonderup, ... The lancet global health 6 (6), e659-e667, 2018 | 47 | 2018 |
| South African guideline for the management of chronic hepatitis B: 2013 CWN Spearman, MW Sonderup, JF Botha, SW Van der Merwe, E Song, ... South African Medical Journal 103 (5), 337-349, 2013 | 46 | 2013 |
| The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up R Hecht, L Hiebert, WC Spearman, MW Sonderup, T Guthrie, TB Hallett, ... Health policy and planning 33 (4), 528-538, 2018 | 45 | 2018 |
| COVID‐19 and the liver: a 2021 update CW Spearman, A Aghemo, L Valenti, MW Sonderup Liver International 41 (9), 1988-1998, 2021 | 44 | 2021 |
